0001140361-14-026486.txt : 20140627 0001140361-14-026486.hdr.sgml : 20140627 20140624093852 ACCESSION NUMBER: 0001140361-14-026486 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20140620 FILED AS OF DATE: 20140624 DATE AS OF CHANGE: 20140624 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WITT DANIEL P CENTRAL INDEX KEY: 0001241030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 14936499 MAIL ADDRESS: STREET 1: C/O REPLIGEN CORP 41 STREET 2: SEYON ST. BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc1.xml FORM 4 X0306 4 2014-06-20 0 0000730272 REPLIGEN CORP RGEN 0001241030 WITT DANIEL P C/O REPLIGEN CORPORATION 41 SEYON STREET SUITE 100, BUILDING 1 WALTHAM MA 02453 0 1 0 0 Senior Vice President Common Stock 2014-06-20 4 M 0 12500 1.83 A 22500 D Common Stock 2014-06-20 4 F 0 1041 21.98 D 21459 D Common Stock 2014-06-20 4 M 0 50000 5.87 A 71459 D Common Stock 2014-06-20 4 F 0 13353 21.98 D 58106 D Common Stock 2014-06-20 4 M 0 15000 3.33 A 73106 D Common Stock 2014-06-20 4 F 0 2273 21.98 D 70833 D Common Stock 2014-06-20 4 M 0 10000 6.23 A 80833 D Common Stock 2014-06-20 4 F 0 2834 21.98 D 77999 D Stock Option (Right to Buy) 1.83 2014-06-20 4 M 0 12500 0 D 2006-05-13 2015-05-13 Common Stock 12500 0 D Stock Option (Right to Buy) 5.87 2014-06-20 4 M 0 50000 0 D 2009-06-06 2018-06-06 Common Stock 50000 0 D Stock Option (Right to Buy) 3.33 2014-06-20 4 M 0 15000 0 D 2011-07-15 2020-07-15 Common Stock 15000 10000 D Stock Option (Right to Buy) 6.23 2014-06-20 4 M 0 10000 0 D 2014-02-28 2023-02-28 Common Stock 10000 30000 D Payment made via forfeiture of 1,041 shares of Common Stock valued at the Closing Price of $21.98 on June 20, 2014. Payment made via forfeiture of 13,353 shares of Common Stock valued at the Closing Price of $21.98 on June 20, 2014. Payment made via forfeiture of 2,273 shares of Common Stock valued at the Closing Price of $21.98 on June 20, 2014. Payment made via forfeiture of 2,834 shares of Common Stock valued at the Closing Price of $21.98 on June 20, 2014. The reporting person previously transferred an employee stock option to purchase 12,500 shares of Common Stock to his ex-wife pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by his ex-wife. /s/ Jeffrey P. Leduc (Attorney in Fact) 2014-06-24 EX-24 2 poa1.htm POWER OF ATTORNEY Unassociated Document

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Walter C. Herlihy, Anthony J. Hunt, and Jeffrey P. Leduc, and any one of them acting singly, the true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the undersigned and in the undersigned's name, place and stead, in any and all capacities (until revoked in writing) to execute for and on behalf of the undersigned, in any and all of the undersigned's capacities, any and all statements on Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by Repligen Corporation (the "Company") in accordance with Sections 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and any and all regulations promulgated thereunder, and to file the same, with all exhibits thereto, and any other documents in connection therewith, with the Securities and Exchange Commission, and with any other entity when and if such is mandated by the Exchange Act or by the By-laws of the Financial Industry Regulatory Authority, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary fully to all intents and purposes as the undersigned might or could do in person thereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorney-in-fact.

IN WITNESS WHEREOF, this Power of Attorney has been signed as of June 23, 2014.


 
/s/ Daniel Witt
 
Name: Daniel Witt